Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: Role of activated macrophages and inflammatory cytokines

Circulation

Volumn 106, Issue 24, 2002, Pages 3024-3030

  Uzui, Hiroyasu ^a   Harpf, Alice ^a   Liu, Ming ^a   Doherty, Terence M ^a   Shukla, Arun ^a   Chai, Ning Ning ^a   Tripathi, Pinky V ^a   Jovinge, Stefan ^a   Wilkin, Douglas J ^a   Asotra, Kamlesh ^a   Shah, Prediman K ^a   Rajavashisth, Tripathi B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; Metalloproteinases; Plaque

Indexed keywords

COLONY STIMULATING FACTOR 1; CYTOKINE; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY SPECIFICITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MACROPHAGE; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SMOOTH MUSCLE FIBER; ZYMOGRAPHY;

ARTERIOSCLEROSIS; BLOTTING, NORTHERN; CATALYSIS; CELL MEMBRANE; CELLS, CULTURED; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; INFLAMMATION MEDIATORS; LIPOPROTEINS, LDL; MACROPHAGE ACTIVATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MATRIX METALLOPROTEINASE 3; MONOCYTES; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037058855     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000041433.94868.12     Document Type: Article

References (25)

1. Glass CK, Witztum JL. Atherosclerosis: The road ahead. Cell. 2001;104:503-516.
2. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
3. Doherty TM, Asotra K, Pei D, et al. Therapeutic developments in matrix metalloproteinase inhibition. Expert Opinion Therapeutic Patents. 2002; 12:665-708.
4. Fini ME, Cook JR, Mohan R, et al. Regulation of matrix metalloproteinase gene expression. In: Parks W, Mecham R, eds. Matrix Metalloproteinases. San Diego, Calif: Academic Press; 1998:300-356.
5. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493-2503.
6. Kai H, Ikeda H, Yasukawa H, et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998;32:368-372.
7. Ye S. Polymorphism in matrix metalloproteinase gene promoters: Implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol. 2000;19:623-629.
8. Xu X-P, Meisel SR, Ong JM, et al. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation. 1999;99:993-998.
9. Rajavashisth TB, Liao JK, Galis ZS, et al. Inflammatory cytokines and oxidized low density lipoprotein increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem. 1999;274:11924-11929.
10. Rajavashisth TB, Xu X-P, Jovinge S, et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: Evidence for activation by proinflammatory mediators. Circulation. 1999:99:3103-3109.
11. Puente XS, Pendas AM, Llano E, et al. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 1996;56:944-949.
12. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advances types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscle Thromb Vasc Biol. 1995;15:1512-1531.
13. Shofuda K, Yasumitsu H, Nishihashi A, et al. Expression of three membrane-type matrix metalloproteinases in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain. J Biol Chem. 1997;272:9749-9754.
14. Berliner JA, Territo MC, Sevanian A, et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990;85:1260-1266.
15. Galis ZS, Muszynski M, Sukhova GK, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
16. Kahari VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med. 1999;31:34-45.
17. Dong Z, Ghabrial M, Katar M, et al. Membrane-type matrix metalloproteinases in mice intracomeally infected with Pseudomonas aeruginosa. Invest Ophthalmol Vis Sci. 2000;41:4189-4194.
18. Pap T, Shigeyama Y, Kuchen S, et al. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum. 2000;43:1226-1232.
19. Shofuda K, Nagashima Y, Kawahara K, et al. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury. Lab Invest. 1998;78:915-923.
20. Nikkari ST, O'Brien KD, Ferguson M, et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995; 92:1393-1398.
21. Henney AM, Wakeley PR, Davies MJ, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
22. Schonbeck U, Mach F, Sukhova GK, et al. Expression of stromelysin-3 in atherosclerotic lesions: Regulation via CD40-CD40 ligand signaling in vitro and in vivo. J Exp Med. 1999;189:843-853.
23. Halpert I, Sires UI, Roby JD, et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A. 1996;93:9748-9753.
24. Whittaker M, Aycough A. Matrix metalloproteinases and their inhibitors: Current status and future challenges. Cell Transmissions. 2001; 17:3-12.
25. Shah PK, Galis ZS. Matrix metalloproteinase hypothesis of plaque rupture: Players keep piling up but questions remain. Circulation. 2001; 104:1878-1880.